Source: ClinicalTrials.gov
Metabolic Effects of Switching From Injectable Semaglutide to Tirzepatide
View on ClinicalTrials.govCitation record
- Study start
- 2026-10-15
- NCT number
- NCT07889453
- Overall status
- Active Not Recruiting
- Study type
- Observational
- Lead sponsor
- LMC Diabetes & Endocrinology Ltd.
- Enrollment
- 650 participants
- Conditions
- Obesity · Type 2 Diabetes (T2D)
- Interventions
- Tirzepatide (Drug)
- Last updated at source
- 22 Oct 2026
- Original source
- https://clinicaltrials.gov/study/NCT07889453
This page reproduces citation metadata only. Inclusion in the Avion Science research library does not imply endorsement and does not establish the safety, efficacy or intended use of any Avion Science compound. Refer to the original record for complete study information.